Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride

Lung cancer is the leading cause of cancer death, and approximately 15% of all lung cancer patients have small-cell lung cancer (SCLC). Although second-line chemotherapy can produce tumor regression, the prognosis is poor. Amrubicin hydrochloride (AMR) is a synthetic anthracycline anticancer agent a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Tatsuo, Kudoh, Shinzoh, Hirata, Kazuto
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076041/
https://www.ncbi.nlm.nih.gov/pubmed/21499556
http://dx.doi.org/10.4137/CMO.S5072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076041/
https://www.ncbi.nlm.nih.gov/pubmed/21499556
http://dx.doi.org/10.4137/CMO.S5072

Ejemplares similares